Literature DB >> 23911822

α1β1 integrin/Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome.

Marisa Zallocchi1, Brianna M Johnson1, Daniel T Meehan1, Duane Delimont1, Dominic Cosgrove2.   

Abstract

Alport syndrome, hereditary glomerulonephritis with hearing loss, results from mutations in type IV collagen COL4A3, COL4A4, or COL4A5 genes. The mechanism for delayed glomerular disease onset is unknown. Comparative analysis of Alport mice and CD151 knockout mice revealed progressive accumulation of laminin 211 in the glomerular basement membrane. We show mesangial processes invading the capillary loops of both models as well as in human Alport glomeruli, as the likely source of this laminin. L-NAME salt-induced hypertension accelerated mesangial cell process invasion. Cultured mesangial cells showed reduced migratory potential when treated with either integrin-linked kinase inhibitor or Rac1 inhibitor, or by deletion of integrin α1. Treatment of Alport mice with Rac1 inhibitor or deletion of integrin α1 reduced mesangial cell process invasion of the glomerular capillary tuft. Laminin α2-deficient Alport mice show reduced mesangial process invasion, and cultured laminin α2-null cells showed reduced migratory potential, indicating a functional role for mesangial laminins in progression of Alport glomerular pathogenesis. Collectively, these findings predict a role for biomechanical insult in the induction of integrin α1β1-dependent Rac1-mediated mesangial cell process invasion of the glomerular capillary tuft as an initiation mechanism of Alport glomerular pathology.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911822      PMCID: PMC3791686          DOI: 10.1016/j.ajpath.2013.06.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  An activating mutant of Cdc42 that fails to interact with Rho GDP-dissociation inhibitor localizes to the plasma membrane and mediates actin reorganization.

Authors:  Richard M Gibson; Payal N Gandhi; Xiaofeng Tong; Jun Miyoshi; Yoshimi Takai; Martha Konieczkowski; John R Sedor; Amy L Wilson-Delfosse
Journal:  Exp Cell Res       Date:  2004-12-10       Impact factor: 3.905

2.  Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome.

Authors:  S Gunwar; F Ballester; M E Noelken; Y Sado; Y Ninomiya; B G Hudson
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

3.  Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.

Authors:  R Kalluri; C F Shield; P Todd; B G Hudson; E G Neilson
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Assembly of type IV collagen. Insights from alpha3(IV) collagen-deficient mice.

Authors:  R Kalluri; D Cosgrove
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

5.  Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.

Authors:  A Hartner; H Schöcklmann; F Pröls; U Müller; R B Sterzel
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

6.  Role for transforming growth factor-beta1 in alport renal disease progression.

Authors:  R Sayers; R Kalluri; K D Rodgers; C F Shield; D T Meehan; D Cosgrove
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

7.  Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

Authors:  D Cosgrove; K Rodgers; D Meehan; C Miller; K Bovard; A Gilroy; H Gardner; V Kotelianski; P Gotwals; A Amatucci; R Kalluri
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

8.  Role of distinct type IV collagen networks in glomerular development and function.

Authors:  S J Harvey; K Zheng; Y Sado; I Naito; Y Ninomiya; R M Jacobs; B G Hudson; P S Thorner
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

9.  Chronology of renal scarring in males with Alport syndrome.

Authors:  C E Kashtan; M C Gubler; S Sisson-Ross; M Mauer
Journal:  Pediatr Nephrol       Date:  1998-05       Impact factor: 3.714

10.  Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.

Authors:  Dale R Abrahamson; Kathryn Isom; Eileen Roach; Larysa Stroganova; Adrian Zelenchuk; Jeffrey H Miner; Patricia L St John
Journal:  J Am Soc Nephrol       Date:  2007-08-15       Impact factor: 10.121

View more
  21 in total

1.  Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.

Authors:  Brianna Dufek; Daniel T Meehan; Duane Delimont; Linda Cheung; Michael Anne Gratton; Grady Phillips; Wenping Song; Shiguang Liu; Dominic Cosgrove
Journal:  Kidney Int       Date:  2016-04-27       Impact factor: 10.612

Review 2.  Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane.

Authors:  Steven D Funk; Meei-Hua Lin; Jeffrey H Miner
Journal:  Matrix Biol       Date:  2018-04-16       Impact factor: 11.583

3.  Endothelin-1 mediated induction of extracellular matrix genes in strial marginal cells underlies strial pathology in Alport mice.

Authors:  Daniel T Meehan; Duane Delimont; Brianna Dufek; Marisa Zallocchi; Grady Phillips; Michael Anne Gratton; Dominic Cosgrove
Journal:  Hear Res       Date:  2016-08-21       Impact factor: 3.208

Review 4.  Searching for a treatment for Alport syndrome using mouse models.

Authors:  Kan Katayama; Shinsuke Nomura; Karl Tryggvason; Masaaki Ito
Journal:  World J Nephrol       Date:  2014-11-06

5.  Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.

Authors:  Kohei Omachi; Rui Miyakita; Ryosuke Fukuda; Yukari Kai; Mary Ann Suico; Tsubasa Yokota; Misato Kamura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  Clin Exp Nephrol       Date:  2017-02-08       Impact factor: 2.801

Review 6.  Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.

Authors:  Dominic Cosgrove; Shiguang Liu
Journal:  Matrix Biol       Date:  2016-08-27       Impact factor: 11.583

Review 7.  Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment.

Authors:  Judy Savige
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

Review 8.  Pathophysiology of the cochlear intrastrial fluid-blood barrier (review).

Authors:  Xiaorui Shi
Journal:  Hear Res       Date:  2016-01-20       Impact factor: 3.208

9.  Pericyte abnormalities precede strial capillary basement membrane thickening in Alport mice.

Authors:  Brianna Dufek; Daniel T Meehan; Duane Delimont; Gina Samuelson; Jacob Madison; Xiourui Shi; Flint Boettcher; Vincent Trosky; Michael Anne Gratton; Dominic Cosgrove
Journal:  Hear Res       Date:  2020-03-18       Impact factor: 3.208

10.  Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.

Authors:  Duane Delimont; Brianna M Dufek; Daniel T Meehan; Marisa Zallocchi; Michael Anne Gratton; Grady Phillips; Dominic Cosgrove
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.